Numerous studies have shown that one of the primary mechanisms that mediates MDR in cancer cells is the overexpression of ABCB1 (i.e., P-gp or MDR1), ABCG2 (i.e., BCRP or MXR), and ABCC1 (i.e., MRP1) transporters (Fletcher et al., 2016), which significantly decrease the intracellular levels of certain anticancer drugs by extrusion from cancer cells, thereby decreasing or even abolishing their efficacy (Wu and Fu, 2018). The gene discussed is ABCG2; the disease is cancer.